Literature DB >> 26032824

Blood transfusion and adverse surgical outcomes: The good and the bad.

Victor A Ferraris1, Marion Hochstetler2, Jeremiah T Martin2, Angela Mahan2, Sibu P Saha2.   

Abstract

INTRODUCTION: Every experienced surgeon has a patient whose life was saved by a blood transfusion (the "good"). In contrast, an overwhelming amount of evidence suggests that perioperative blood transfusion can be associated with adverse surgical outcomes (the "bad"). We wondered what patient characteristics, if any, can explain this clinical dichotomy with certain patients benefiting from transfusion, whereas others are harmed by this intervention.
METHODS: We queried the American College of Surgeons National Surgical Quality Improvement Project database containing patient information entered between 2010 and 2012 to identify differences in mortality and morbidity among patients receiving blood transfusion within 72 hours of their operative procedure compared with those who did not receive any blood. We calculated the relative risk of developing a serious complication or of operative mortality in propensity-stratified patients with equivalent predicted risk of developing a serious complication or operative mortality.
RESULTS: There were 470,407 patients in the study group. Of these, 32,953 patients (7.0%) received at least a single blood transfusion within 72 hours of operation. The percent of transfused patients who died or developed serious morbidity was 11.3% and 55.4% compared with 1.3% and 6.1% in nontransfused patients (both P < .001). Operative mortality, rates of failure to rescue, and serious postoperative complications are increased in patients who receive a postoperative transfusion, both in unadjusted comparisons and in propensity-matched comparisons. Dividing patients into regression-stratified deciles with equal numbers of deaths in each group found that patients at the greatest risk for development of death or serious complications had nonsignificant risk of harm from blood transfusion, whereas patients in the least risk deciles had between an 8- and 12-fold increased risk of major adverse events associated with transfusion.
CONCLUSION: We found that high-risk patients do not have a significant risk from blood transfusion, but low-risk patients have between an 8- and 10-fold excess risk of adverse outcomes when they receive a blood transfusion. We speculate that careful preoperative assessment of transfusion risk and intervention based on this assessment could minimize operative morbidity and mortality, especially because the patients at least risk are more likely to undergo elective operations and provide time for therapeutic interventions to improve transfusion risk profiles. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26032824     DOI: 10.1016/j.surg.2015.02.027

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  21 in total

1.  Risk Factors for Transfusions Following Total Joint Arthroplasty in Patients With Rheumatoid Arthritis.

Authors:  Elizabeth Salt; Amanda T Wiggins; Mary Kay Rayens; Katelyn Brown; Kate Eckmann; Andrew Johannemann; Raymond D Wright; Leslie J Crofford
Journal:  J Clin Rheumatol       Date:  2018-12       Impact factor: 3.517

2.  Preoperative anemia-screening clinics.

Authors:  Yulia Lin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Prehospital Blood Transfusions in Non-Trauma Patients.

Authors:  Cornelius A Thiels; Johnathon M Aho; Aoidhnait S Fahy; Maile E Parker; Amy E Glasgow; Kathleen S Berns; Elizabeth B Habermann; Scott P Zietlow; Martin D Zielinski
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

4.  STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management.

Authors:  Pierre Tibi; R Scott McClure; Jiapeng Huang; Robert A Baker; David Fitzgerald; C David Mazer; Marc Stone; Danny Chu; Alfred H Stammers; Tim Dickinson; Linda Shore-Lesserson; Victor Ferraris; Scott Firestone; Kalie Kissoon; Susan Moffatt-Bruce
Journal:  J Extra Corpor Technol       Date:  2021-06

5.  Randomized controlled trials vs. observational studies: why not just live together?

Authors:  David Faraoni; Simon Thomas Schaefer
Journal:  BMC Anesthesiol       Date:  2016-10-21       Impact factor: 2.217

6.  Observational studies - should we simply ignore them in assessing transfusion outcomes?

Authors:  Kevin Trentino; Shannon Farmer; Irwin Gross; Aryeh Shander; James Isbister
Journal:  BMC Anesthesiol       Date:  2016-10-14       Impact factor: 2.217

7.  Efficacy of aminocaproic acid in the control of bleeding after total knee and hip arthroplasty: A systematic review and meta-analysis.

Authors:  Yihua Li; Jianwen Wang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 8.  Efficiency and safety of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A systematic review and meta-analysis.

Authors:  Chuan-Xiu Sun; Lu Zhang; Li-Dong Mi; Guang-Yu Du; Xue-Gang Sun; Sheng-Wei He
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

9.  Prediction of perioperative transfusions using an artificial neural network.

Authors:  Steven Walczak; Vic Velanovich
Journal:  PLoS One       Date:  2020-02-24       Impact factor: 3.240

10.  Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol.

Authors:  Linyu Yang; Xufeng Jia; Jian Yang; Jianping Kang
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.